Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas
ClinicalTrials.gov study NCT06248086. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03064867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT03895944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ctDNA and Metabolites in CSF as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04112238. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT05359211. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.
ClinicalTrials.gov study NCT03146533. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT05613348. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
ClinicalTrials.gov study NCT03997968. IPD Sharing: NO. Countries: 1. Publications: 0.
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00062296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial
ClinicalTrials.gov study NCT03003546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04539444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
ClinicalTrials.gov study NCT07070648. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT04435743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)
ClinicalTrials.gov study NCT05844956. IPD Sharing: NO. Countries: 1. Publications: 0.
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
ClinicalTrials.gov study NCT06863402. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT02633111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients
ClinicalTrials.gov study NCT06029634. IPD Sharing: NO. Countries: 1. Publications: 0.
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06447987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines
ClinicalTrials.gov study NCT01432158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma
ClinicalTrials.gov study NCT04246359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.